Top

States Try to Obscure Execution Details as Drugmakers Hinder Lethal Injection

Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate

After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens

Almond, Soy Drinks Can Be Called Milk, FDA Proposes

GSK and Vir Biotech amend COVID-19 research partnership

Tag: AADC

Cell and Gene Therapy, Industry

New targeted gene therapy could reverse neurological diseases

July 14, 2021

Via: European Pharmaceutical Review

A research team in the US have created a new, targeted method of gene therapy that could help children born with a rare genetic disorder called aromatic L-amino acid decarboxylase (AADC) deficiency. The disease is characterised by deficient synthesis of […]